Page last updated: 2024-08-05 11:35:24

bisbenzylisoquinoline alkaloid

A type of benzylisoquinoline alkaloid whose structures are built up of two benzylisoquinoline units linked by ether bridges. Various structural patterns resulting from additional bridging between the two units by direct carbon-carbon bridging or by methylenedioxy groups are common.

ChEBI ID: 133004

Members (13)

MemberDefinitionRole
bebeerine(+)-Bebeerine
berbamineBerbamine
cepharanthineA bisbenzylisoquinoline alkaloid from tubers of Stephania; stimulates recovery of immunologic function in lymphatic system after administration of antineoplastic agents or x-irradiation.cepharanthine
cycleanineCycleanine
dauricineA bisbenzylisoquinoline alkaloid resulting from the formal oxidative dimerisation of 4-{[(1R)-6,7-dimethoxy-2-methyl-1,2,3,4-tetrahydroisoquinolin-1-yl]methyl}phenol by attachment of the phenolic oxygen of one molecule to the benzene ring of the second (ortho to the phenolic hydroxy group of the latter).dauricine
fangchinolineA bisbenzylisoquinoline alkaloid that is (1beta)- berbaman which has been substituted by methyl groups at the 2 and 2' positions, by methoxy groups at the 6, 6', and 12 positions, and by a hydroxy group at position 7. Isolated from Stephania tetrandra, it has been found to possess neuroprotective and anti-tumour activity.fangchinoline
guatteguamerineMagnoline
hernandezineHernandezine
obamegineObamegine
oxyacanthineA macrocycle that is oxyacanthan that is substituted by methoxy groups at positions 6, 6', and 7, methyl groups at positions 2 and 2', and a hydroxy group at the 12' position.oxyacanthine
tetrandrine(+)-Tetrandrine
thalicarpinethalicarpine
tubocurarineA benzylisoquinoline alkaloid muscle relaxant which constitutes the active component of curare.tubocurarine

Research

Studies (5,529)

TimeframeStudies, Drugs in This Class (%)All Drugs %
pre-19903,691 (66.76)18.7374
1990's811 (14.67)18.2507
2000's476 (8.61)29.6817
2010's400 (7.23)24.3611
2020's151 (2.73)2.80

Study Types

Publication TypeStudies, Drugs in This Class (%)All Drugs (%)
Trials164 (2.70%)5.53%
Reviews153 (2.52%)6.00%
Case Studies87 (1.43%)4.05%
Observational1 (0.02%)0.25%
Other5,678 (93.34%)84.16%